Area Under the Curve (AUC)

    From Longevity Wiki
    (Redirected from AUC)

    The Area Under the Curve (AUC) is a critical parameter in pharmacokinetics, representing the integral of the drug concentration-time curve. It quantifies the total drug exposure over time, providing vital information on drug absorption, distribution, metabolism, and elimination.



    • is the drug concentration at time

    AUC offers insight into the extent and rate of drug absorption, making it a fundamental measure to assess bioavailability and bioequivalence of drugs.

    Types of AUC

    Several types of AUC values exist, each serving unique purposes in pharmacokinetic studies:

    Type Description Application
    Area under the concentration-time curve up to the last measurable concentration. Used to determine the total exposure of the body to the drug until the last measurable concentration.
    Represents the total area under the concentration-time curve from administration to infinity. Provides an estimate of the total exposure of the body to a drug. Useful for evaluating the overall efficacy of a drug.
    Area under the concentration-time curve from the administration up to a specific time 't'. Useful for focusing on drug exposure within specific time windows.
    Area under the concentration-time curve from administration up to 24 hours. Often used when drugs are administered once a day.
    Area under the concentration-time curve over a dosing interval 'tau', for example in repeated dosing every 12 or 24 hours. Helpful in evaluating steady-state pharmacokinetics in multiple dosing regimens.
    Utilizes microdosing studies and mass spectrometric analyses to determine the AUC for drugs administered in very low concentrations. Suitable for studying the pharmacokinetics of drugs at subtherapeutic, micro-level doses.


    AUC is indispensable in pharmacology and drug development:

    • It is pivotal for determining the dosage and frequency of drug administration.
    • It aids in evaluating the bioequivalence of generic drugs to brand-name counterparts.
    • It enables researchers to study the pharmacokinetics of new drug candidates.

    See Also